4157 On Other Exchanges
Symbol
Exchange
Taiwan
text size: T | T
Back to Snapshot
Company Description

Contact Info

138 Shin Ming Road

7th Floor

Neihu District

Taipei, 114

Taiwan

Phone: 886 2 8177 7072

Fax: 886 2 2796 3606

TaiGen Biopharmaceuticals Holdings Limited, through its subsidiary, TaiGen Biotechnology Co., Ltd., engages in the development of novel therapeutics for infectious diseases, cancer, and diabetes-related complications in Taiwan and internationally. Its product portfolio includes Taigexyn (Nemonoxacin), a novel non-fluorinated quinolone antibacterial drug for the treatment of bacterial infections. The company’s development projects comprise Nemonoxacin for treating community-acquired pneumonia and diabetic foot infection; Burixafor (TG-0054), a CXCR4 chemokine receptor antagonist for stem cell transplantation and hematological cancer chemosensitization, as well as for treating myocardial infarction; and Furaprevir (TG-2349), a novel inhibitor of Hepatitis C virus NS3/4A protease. TaiGen Biopharmaceuticals Holdings Limited was founded in 2001 and is based in Taipei, Taiwan.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4157 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4157.
View Industry Companies
 

Industry Analysis

4157

Industry Average

Valuation 4157 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 673.9x
Price/Book 10.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 624.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TAIGEN BIOPHARMACEUTICALS, please visit www.taigenbiotech.com.tw. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.